Literature DB >> 25310666

[Severe traumatic braininjury in children and adolescents].

Luís Fernando Andrade de Carvalho1, Carolina de Araújo Affonseca2, Sérgio Diniz Guerra3, Alexandre Rodrigues Ferreira4, Eugênio Marcos Andrade Goulart4.   

Abstract

BACKGROUND AND OBJECTIVES: Present a critical review of traumatic brain injury (TBI) in children and adolescents, focusing on severe TBI, the mortality and the factors related with poor outcome. CONTENTS: It was made a systematic review in MEDLINE, SciElo e Lilacs, with the key words: traumatic brain injury, craniocerebral trauma, children and mortality. The most important articles related in the Guidelines of Brain Trauma Foundation (2000 e 2003) were selected too. TBI is one of the most important causes of mortality and morbidity in children and adolescents, and morbidity in children and adolescents. The mortality variation was between 10% and 55%, depending of the patients select criteria, trauma severity and units where the studies were made. The children mortality was, in general, lower than that found in adults and the most important factors related with an increased mortality were: Glasgow Coma Score, hypotension, cerebral swelling and lower cerebral perfusion press. Severe TBI endpoint treatment is to correct the secondary brain lesions related factors.
CONCLUSIONS: The factors related with better outcomes in children with severe TBI are still obscures, despite the large number of studies, large numbers of studies. Many of these factors can be avoided or correct by aggressive fluid resuscitation, surgery treatment, monitoration and adequate intensive care.

Entities:  

Year:  2007        PMID: 25310666

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  1 in total

1.  Central auditory processing in children after traumatic brain injury.

Authors:  Carolina Calsolari Figueiredo de Godoy; Adriana Neves Andrade; Italo Suriano; Carla Gentile Matas; Daniela Gil
Journal:  Clinics (Sao Paulo)       Date:  2022-10-03       Impact factor: 2.898

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.